The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-Amino(cyclopropyl)methylene)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide ID: ALA4085754
PubChem CID: 137643124
Max Phase: Preclinical
Molecular Formula: C26H23Cl2N5O2S
Molecular Weight: 540.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N/C(=N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C1CC1
Standard InChI: InChI=1S/C26H23Cl2N5O2S/c27-20-10-8-18(9-11-20)24-23(17-4-2-1-3-5-17)16-33(31-24)26(30-25(29)19-6-7-19)32-36(34,35)22-14-12-21(28)13-15-22/h1-5,8-15,19,23H,6-7,16H2,(H2,29,30,32)
Standard InChI Key: YBOYWYPZUYVOHH-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
23.8719 -16.4718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0865 -15.6835 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.2965 -15.8918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6226 -13.2178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3026 -13.6710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.9450 -13.1658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6608 -12.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8452 -12.4327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3347 -14.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6435 -14.9236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0579 -14.8681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9203 -14.5431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2292 -14.9791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8131 -16.0651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8422 -16.8809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5645 -17.2614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2566 -16.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2218 -16.0046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4990 -15.6278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3411 -11.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6444 -11.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1382 -10.3926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3287 -10.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0280 -11.2753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5361 -11.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1096 -11.7191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9262 -11.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3783 -11.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0149 -10.3590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1949 -10.3101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7465 -10.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8209 -9.8706 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.9803 -17.2048 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.5070 -13.8303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5054 -13.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7926 -13.4198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 2 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 2 0
12 13 1 0
11 2 1 0
2 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
8 20 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
7 26 1 0
23 32 1 0
17 33 1 0
12 34 1 0
35 34 1 0
36 35 1 0
34 36 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 540.48Molecular Weight (Monoisotopic): 539.0950AlogP: 5.31#Rotatable Bonds: 5Polar Surface Area: 100.48Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 7.66CX LogP: 5.28CX LogD: 4.83Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.35Np Likeness Score: -0.86
References 1. Iyer MR, Cinar R, Katz A, Gao M, Erdelyi K, Jourdan T, Coffey NJ, Pacher P, Kunos G.. (2017) Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis., 60 (3): [PMID:28085283 ] [10.1021/acs.jmedchem.6b01504 ]